Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Christopher Booth (Mead/Jacobsen group) and Marieke Oudelaar (Hughes/Higgs group), who won this year’s Radcliffe Department of Medicine Graduate Prize.


Chris Booth completed his DPhil under the supervision of Adam Mead and Sten Eirik Jacobsen. Chris led a study that provided experimental evidence that the phenotypic and gene expression profiles of a cancer can be traced back to those of the cell of origin. For the first time since the identification of human early thymic progenitor (ETP) leukemia, Chris confirmed that ETPs do indeed possess the potential to become LSCs upon introduction of recurrent ETP leukemia associated mutations. Chris published his findings in a first author article in Cancer Cell and has given oral presentations of his work at two international meetings. Find out more his work

 

 

Marieke Oudelaar completed her DPhil under the supervision of Doug Higgs and Jim Hughes. Her research describing chromosomal interactions within single cells has made a major contribution to recent developments in the application of Chromosome Conformation Capture techniques. Although this won’t have an immediate clinical application, it will, in time have a very large impact on the field. Marieke’s research is published in Nature Genetics. Find out more about her work. 

 

Find out more about the prize on the RDM website.

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.